Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Haleos Labs Ltd

NSE: HALEOSLABS · BSE: 540679 · Pharmaceuticals & Biotechnology · 24 announcements

Share price
₹1,587.00
Market cap
₹479.8 Cr
Revenue (annual)
₹333.8 Cr
Net profit (annual)
₹17.31 Cr
P/E (TTM)
30.4×Sector 47.4×
Promoter holding
72.11%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:33 IST BSE
Management Change

Haleos Labs Management Change

Haleos Labs Limited has re-appointed Dr. Mannam Malakondaiah and Dr. Srinivas Samavedam as Independent Directors for five-year terms starting November 13, 2026. Shareholder approval is required.

Execution
5 years
20:14 IST NSE
Management Change

Haleos Labs Management Change

Haleos Labs Limited re-appointed Sudeepthi Gopineedi as Executive Director while Independent Director Sundaramma Patibandla resigned. The board also appointed new statutory and cost auditors.

20:07 IST BSE
Management Change

Haleos Labs Management Change

Haleos Labs appointed Suryanarayana & Suresh as Statutory Auditors for five years. Annapragada & Co. was also reappointed as Cost Auditors for fiscal 2026-27.

Execution
5 years
20:02 IST BSE
Management Change

Haleos Labs Management Change

Mrs. Sundaramma Patibandla resigned as Independent Director of Haleos Labs Limited effective May 29, 2026. The board remains compliant with SEBI governance requirements post-resignation.